Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Review
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,705 | Dovepress* | 11,887+ | 1,889 | 13,776 | |
| PubMed Central* | 1,818 | 686 | 2,504 | ||
| Totals | 13,705 | 2,575 | 16,280 | ||
| *Since 15 August 2019 | |||||
View citations on PubMed Central and Google Scholar